Why the study?
Does short-term (1-3 months) DAPT improve bleeding outcomes without increasing ischemic events compared to standard (12 months) DAPT in patients undergoing implantation of a new-generation DES?
Does short-term (1-3 months) DAPT improve bleeding outcomes without increasing ischemic events compared to standard (12 months) DAPT in patients undergoing implantation of a new-generation DES?
In patients receiving new-generation DES, 1-3 months of DAPT reduces bleeding risk without compromising protection against stent thrombosis, MI, or death compared to standard 12-month DAPT.
Answers are grounded in this paper and cite their sources.
May favor 1-3 month DAPT after new-generation DES to reduce bleeding; confirms noninferior ischemic protection in this meta-analysis.
In patients undergoing implantation of a new-generation of DES, short-term (1-3 months) DAPT exhibited no inferiority compared with standard (12 months) DAPT in terms of all-cause mortality, cardiac death, myocardial infarction, stroke, and definite or probable stent thrombosis compared with standard (12 months) DAPT. However, short-term DAPT appeared superior to standard DAPT in terms of major bleeding and all bleeding.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: